{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:58:17Z","timestamp":1792803497018,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.radonc.2025.111165","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:22:34Z","timestamp":1759591354000},"page":"111165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6414-0422","authenticated-orcid":false,"given":"M.","family":"Vandemaele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lewison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Martinussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-6308","authenticated-orcid":false,"given":"J.M.","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-1633","authenticated-orcid":false,"given":"M.","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-3730","authenticated-orcid":false,"given":"Y.","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111165_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","article-title":"The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis","volume":"116","author":"Borras","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.radonc.2017.11.004","article-title":"The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits","volume":"126","author":"Hanna","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2022.01.053","article-title":"Is Clinical research serving the needs of the global cancer burden? An analysis of contemporary global radiation therapy randomized controlled trials","volume":"113","author":"Dodkins","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111165_b0025","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(22)00540-X","article-title":"European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission","volume":"24","author":"Lawler","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijrobp.2018.03.009","article-title":"Radiation therapy research: a global analysis 2001-2015","volume":"101","author":"Aggarwal","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111165_b0035","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/S1470-2045(18)30917-3","article-title":"Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspective","volume":"20","author":"Lievens","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","article-title":"Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments","volume":"24","author":"McIntosh","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0045","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2018.04.030","article-title":"Failed randomized clinical trials in radiation oncology: what can we learn?","volume":"101","author":"Nguyen","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111165_b0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-023-02801-7","article-title":"Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions","volume":"18","author":"Hulstaert","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.radonc.2025.111165_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hec.3479","article-title":"Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments","volume":"26","author":"Ciani","year":"2017","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2025.111165_b0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1470-2045(23)00319-4","article-title":"Common sense oncology: outcomes that matter","volume":"24","author":"Booth","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2011.09.008","article-title":"A clinical approach to technology assessment: how do we and how should we choose the right treatment?","volume":"22","author":"Zietman","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111167","article-title":"Building an appraisal framework for radiotherapy innovations in a value-based context: the ESTRO-VBRO categorisation system","author":"Vandemaele","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.radonc.2025.111165_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochemia medica"},{"key":"10.1016\/j.radonc.2025.111165_b0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ijrobp.2022.12.044","article-title":"Characteristics of global radiation therapy trials between 2017 and 2022: a cross-sectional study","volume":"116","author":"Chen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111165_b0090","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaoncol.2018.0887","article-title":"Characteristics of radiotherapy trials compared with other oncological clinical trials in the past 10 years","volume":"4","author":"Liu","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0095","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S1470-2045(11)70379-5","article-title":"Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?","volume":"13","author":"van Loon","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41591-023-02732-7","article-title":"The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring","volume":"30","author":"Marcus","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2025.111165_b0105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.radonc.2025.111165_b0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1109978","article-title":"Cancer treatment data available in European cancer registries: where are we and where are we going?","volume":"13","author":"Giusti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(23)02199-2","article-title":"The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology","volume":"403","author":"Leary","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111165_b0130","article-title":"Reporting breast cancer radiation therapy details in studies and daily practice: Nice-to-have or a must-have?","volume":"110429","author":"Boersma","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hec.4575","article-title":"Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?","volume":"31","author":"Klein","year":"2022","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2025.111165_b0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hec.4478","article-title":"Coverage with evidence development for medical devices in Europe: can practice meet theory?","volume":"31","author":"Drummond","year":"2022","journal-title":"Health Econ"},{"key":"10.1016\/j.radonc.2025.111165_b0145","article-title":"Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013\u20132019): a nationwide registry-based prospective study. the Lancet Regional Health \u2013","volume":"44","author":"Lievens","year":"2024","journal-title":"Europe"},{"key":"10.1016\/j.radonc.2025.111165_b0150","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1016\/S1470-2045(16)30572-1","article-title":"Relevance of randomised controlled trials in oncology","volume":"17","author":"Tannock","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0155","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(14)70375-4","article-title":"Outcomes and endpoints in trials of cancer treatment: the past, present, and future","volume":"16","author":"Wilson","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110060","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","volume":"195","author":"Kaidar-Person","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0165","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111165_b0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2021.05.007","article-title":"Value-based radiotherapy: a new chapter of the ESTRO-HERO project","volume":"160","author":"Lievens","year":"2021","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025051692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025051692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:16:24Z","timestamp":1780546584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025051692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S0167814025051692"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111165","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111165"}}